Rationale for randomized controlled trials and for intention-to-treat analysis in transfusion medicine: Are they one and the same?

Vox Sanguinis

Volumn 95, Issue 3, 2008, Pages 165-173

  Vamvakas, E C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Equivalence trials; Intention to treat vs. as treated analyses; Methods; Non inferiority trials; Randomized controlled trials

Indexed keywords

BLOOD TRANSFUSION; CLINICAL RESEARCH; ERYTHROCYTE TRANSFUSION; HEALTH CARE PERSONNEL; HUMAN; MEDICAL LITERATURE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TREATMENT PLANNING;

ERYTHROCYTE TRANSFUSION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 51749097561     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01089.x     Document Type: Review

References (32)

1. Schwartz D, Lellouch J: Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis 1967 20: 637 648
2. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1976 34: 585 612
3. Newell DJ: Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol 1992 21: 837 841
4. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB: Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 1991 10: 1595 1160
5. Hollis S, Campbell F: What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999 319: 670 674
6. Ellenberg JH: Intent to treat analysis versus as-treated analysis. Drug Inf J 1996 30: 535 544
7. Ruiz-Canella M, Martinez-Gonzalez MA, de Irala-Estevez J: Intention-to-treat analysis is related to methodological quality. BMJ 2000 320: 670 674
8. Bradford-Hill A: Principles of Medical Statistics, 7th edn. The Lancet, London, 1961, p. 259
9. Schwartz D, Flamand R, Lellouch J: Clinical Trials. Academic Press, London, 1980
10. Armitage P: The analysis of data from clinical trials. The Statistician 1979 28: 171 183
11. Detre K, Peduzzi P: The problem of attributing deaths of nonadherers: the VA coronary bypass experience. Controlled Clin Trials 1982 3: 355 364
12. Sackett DL, Gent M: Controversy in counting and attributing events in clinical trials. N Engl J Med 1979 301: 1410 1412
13. Mahoer D, Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc 2001 91: 437 442
14. Lewis JA, Machin D: Intention to treat - who should use ITT. Br J Cancer 1992 68: 647 650
15. Fergusson D, Aaron SD, Guyatt G, Hébert P: Post-randomization exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002 325: 652 654
16. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998 176: 462 466
17. Fergusson D, Khanna MP, Tinmouth A, Hébert PC: Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth 2004 51: 417 424
18. Blumberg N, Zhao H, Wang H, Messing S, Heal JM, Lyman GH: The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion 2007 47: 573 581
19. Kunz R, Guyatt G: Which patients to include in the analysis? Transfusion 2006 46: 881 884
20. Vamvakas EC: White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis. Vox Sang 2007 92: 224 232
21. Vamvakas EC, Carven JH: Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999 39: 701 710
22. Nathens AB, Nester TA, Rubenfeld GD, Nirula R, Gernsheimer TB: The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006 26: 342 347
23. Ellenberg SS, Temple R: Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: Practical issues and specific cases. Ann Intern Med 2000 133: 464 470
24. Kaul S, Diamond GA: Good enough: a primer on the analysis and interpretation of noninferiority trials. Ann Intern Med 2006 145: 62 69
25. Siegel JP: Equivalence and noninferiority trials. Am Heart J 2000 139: S166 S170
26. Blackwelder WC: Current issues in clinical equivalence trials. J Dent Res 2004 83 (Special Issue C C113 C115
27. Jones B, Jarvis P, Lewis TA, Ebbutt AF: Trials to assess equivalence: the importance of rigorous methods. BMJ 1996 313: 36 39
28. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tagnoni G, Barbui T, Mandelli F, Sirchia G: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997 337: 1870 1875
29. Tinmouth A, Tannock IF, Grump M, Tomlinson G, Brandwein J, Minden M, Sutton D: Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 2004 44: 1711 1719
30. Heddle NM, Cook RJ, Blajchman MA, Barty RL, Sigouin CS, Boye DM, Nelson EJ, Kelton JG: Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial. Transfusion 2005 45: 896 903
31. Heddle NM, Cook RJ: Design issues with clinical experimental platelet transfusion studies. Transfusion Alternatives in Transfusion Medicine 2006 8: 106 113
32. Salsbury D: Intent to treat: the reductio ad absurdum that became gospel. Pharmacoepidemiol Drug Saf 1994 3: 329 335